The Different Mechanisms of Cancer Drug Resistance: A Brief Review.
Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. · 2017
Read The Different Mechanisms of Cancer Drug Resistance: A Brief Review. by Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5651054.txt.
Description
Mansoori and co-authors present a brief review in Advanced Pharmaceutical Bulletin. It explains how cancers resist anticancer drugs. Resistance helps cause most chemotherapy failures in advanced disease. The authors sort the causes into clear groups. Some are built into the tumor from the start. Others are acquired during treatment.
Mechanisms include drug inactivation and multi-drug resistance. Cells may block their own death pathways. They may change how drugs are broken down. Epigenetic shifts and altered drug targets also play roles. Faster DNA repair and gene amplification add to the problem. The review closes with treatment failures by drug type. It also proposes fresh strategies to beat resistance.
Catalog record
| CREATOR | Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |